Most people come in having already heard the brand names — Ozempic, Wegovy, Mounjaro, Zepbound — without anyone explaining what the medication is actually doing once it’s in your body. That matters, because understanding the mechanism is what tells you whether it’s likely to help you, what side effects to expect, and why stopping it tends to undo the results.
Here’s the plain-language version.
The short answer
GLP-1 medications copy a hormone your gut already makes after you eat. That hormone tells your brain you’ve had enough and tells your stomach to empty more slowly. The medication keeps that signal switched on far longer than your own hormone does — so you feel full sooner, stay full longer, and think about food less.
It isn’t willpower in an injection. It’s a change to the biological signal that decides when you feel satisfied.
What GLP-1 actually is
GLP-1 stands for glucagon-like peptide-1. It’s a hormone released by cells in your small intestine within minutes of food arriving. It does several things at once: it prompts insulin release when blood sugar rises, slows how fast your stomach empties, and acts on appetite centers in the brain.
Your own natural GLP-1 breaks down within a couple of minutes. The medications are engineered to resist that breakdown, which is why most are a once-weekly injection rather than something you take with every meal.
Two are commonly prescribed for weight management:
- Semaglutide (sold as Wegovy for weight loss, Ozempic for type 2 diabetes) acts on the GLP-1 receptor.
- Tirzepatide (Zepbound for weight loss, Mounjaro for diabetes) acts on the GLP-1 receptor and a second one called GIP. That dual action is why it tends to produce more weight loss in studies.
If you’re trying to decide between the two, we go through that in detail in semaglutide vs. tirzepatide.
What the medication does in your body
Four things happen, and they compound:
1. Your stomach empties more slowly. Food stays put longer, so fullness after a meal lasts well beyond the meal itself. This is also the main reason for the nausea some people get early on.
2. Appetite signaling in the brain changes. This is the part patients describe most often — the constant background negotiation about food quiets down. People frequently call it “food noise,” and its absence is usually the first thing they notice, often before the scale moves.
3. Insulin response improves. When blood sugar rises, the medication supports a more appropriate insulin response, and it blunts glucagon, the hormone that pushes blood sugar up.
4. You eat less without white-knuckling it. Portions shrink because you’re satisfied sooner, not because you’re enduring hunger. That’s the practical difference between this and most diets.
Does it actually work?
Yes, and the trial data is unusually clear for a weight-loss intervention.
In the STEP 1 trial, adults taking once-weekly semaglutide 2.4 mg lost an average of 14.9% of their body weight over 68 weeks, compared with 2.4% on placebo. (source)
In SURMOUNT-1, participants on the highest dose of tirzepatide lost an average of 20.9% of their body weight over 72 weeks, against 3.1% on placebo. (source)
For context, that’s weight loss in a range previously seen mainly with surgery.
Two honest caveats. Those are averages — individual results vary widely, and some people respond far less. And both trials paired the medication with lifestyle counseling, which is part of why the dosing alone isn’t the whole program.
Do you need a prescription?
Yes. Semaglutide and tirzepatide are prescription medications in the United States. They require evaluation, lab work, and ongoing monitoring — both to confirm they’re appropriate for you and to adjust dosing as you go.
They are not available over the counter, and products marketed online as GLP-1 alternatives without a prescription are not the same medications.
Is it safe?
For most people who are appropriate candidates, yes — but there are real side effects, and they’re mostly digestive.
The common ones are nausea, vomiting, diarrhea, and constipation. These tend to be worst in the first weeks and after each dose increase, and they usually settle. Starting low and increasing slowly is the single biggest lever for tolerability, which is why dose escalation shouldn’t be rushed.
There are also people who shouldn’t take these medications, including anyone with a personal or family history of medullary thyroid carcinoma or MEN2. That’s a conversation to have before the first dose, not after, and it’s part of why this needs a provider rather than a website.
What these medications don’t do
This is the part that gets skipped, and it’s the part that determines whether results last.
They don’t protect your muscle. Rapid weight loss costs lean mass as well as fat, and losing muscle slows your metabolism — which works directly against you later. Protein intake and resistance training aren’t optional add-ons here. We cover this in losing muscle on GLP-1 medications.
They don’t fix an underlying hormone or thyroid problem. If your thyroid is underperforming or your hormones are off, a GLP-1 can mask that while the root cause sits there untreated. This is one of the more common things we find on bloodwork in people who’ve plateaued.
They don’t work once you stop. The medication changes the appetite signal while you’re taking it. When it’s withdrawn without a plan, appetite returns and so, usually, does the weight — the STEP 4 withdrawal trial was designed specifically to test this. (source) An exit strategy is part of the program, not an afterthought.
Frequently Asked Questions
How fast does it start working?
Appetite changes are often noticeable within the first week or two. Meaningful weight change takes longer — the trial results above were measured over roughly 15 to 18 months.
Do I have to inject it?
The weight-management versions are once-weekly injections, given with a very short needle into the abdomen, thigh, or upper arm. Most people manage it themselves after one demonstration.
Will I have to take it forever?
Not necessarily, but obesity behaves as a chronic condition, and stopping without a maintenance plan usually means regain. We’d rather plan the off-ramp with you than have you discover that on your own.
Is one better than the other?
Tirzepatide produced more weight loss in trials, but the right choice depends on your health history, tolerance, and cost. That’s covered in the comparison post.
How we approach it in Glendale
We don’t prescribe these on their own. Every weight-loss program here starts with bloodwork — thyroid, metabolic markers, and hormones — because treating appetite while ignoring an underactive thyroid or a hormone imbalance produces exactly the plateau people come to us frustrated about.
From there it’s the right medication at the right pace, protein and strength guidance to protect lean mass, and regular check-ins to adjust rather than a prescription and a wave goodbye.
If you want to know whether a GLP-1 is a reasonable fit for you, see our medical weight loss program or call (623) 259-6900 for a free 15-minute discovery call. We’ll tell you honestly if we don’t think it’s the right tool for your situation.
Sources
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384(11):989-1002. PubMed
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205-216. PubMed
- Rubino D, et al. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (STEP 4). JAMA. 2021;325(14):1414-1425. PubMed
Jess Morgan, MSN, APRN, FNP-C is a board-certified family nurse practitioner and WorldLink Medical-certified hormone specialist at Total Medical & Wellness in Glendale, Arizona. This article is general health information and is not a substitute for individual medical advice.
